Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Outcome of Board Meeting held on March 17, 2026.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Lotus Eye Hospital and Institute Limited, at its meeting held on March 17, 2026, decided not to proceed with the proposed voluntary delisting of its equity shares from the National Stock Exchange of India (NSE). The decision was taken after considering current market conditions, liquidity factors, and the need to ensure continued investor convenience and flexibility. As a result, the company will continue to remain listed on both BSE (Scrip Code: 532998) and NSE (Scrip Code: LOTUSEYE). The board meeting was held from 4:30 PM to 5:00 PM and the outcome was communicated by the Company Secretary, Prathish S.
This is a neutral-to-mildly positive development for shareholders, as the company has decided to retain its NSE listing, ensuring continued liquidity and trading convenience. Investors who were concerned about potential delisting-related uncertainty can now expect normal trading to continue on both exchanges.